9 Best Healthcare Stocks with the Highest Upside
Talking about how people are feeling the impact of the shutdown, Dr.
Beam Therapeutics Inc. (BEAM)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 4,682 | $113,632 | 0.05% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $26.68 | 459 | $12,246.12 | 14 | 2025-10-27 | Filing | |
| $24.53 | 467 | $11,455.51 | 44,045 | 2025-10-01 | Filing | |
| $24.53 | 373 | $9,149.69 | 116,921 | 2025-10-01 | Filing | |
| $24.63 | 25,000 | $615,667.50 | 986,667 | 2025-10-02 | Filing | |
| $24.51 | 25,000 | $612,655.00 | 986,667 | 2025-10-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,830,738 | $117,242,011 | 0.07% | |
| 2. | 94,630 | $2,296,670 | 0.01% | |
| 3. | 70,280 | $1,705,696 | 0% | |
| 4. | 60,615 | $1,471,126 | 0.09% | |
| 5. | 41,831 | $1,015,238 | 0.01% |
News See All
What Does Wall Street Think About Beam Therapeutics (BEAM)?
Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the best biotech stocks with high potential. H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Beam Therapeutics Inc.
14 Biotech Stocks with High Potential
Healthcare was the second worst performer this year, with pharma and biotech companies under pressure.
H.C. Wainwright Maintains Buy on Beam (BEAM), $80 Target on Pipeline Momentum
Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the best emerging technology stocks to buy right now.
11 Best Emerging Technology Stocks to Buy Right Now
While the telephone brought comfort, smartphones changed lives. While factories powered economies, artificial intelligence began rewriting them.
JonesTrading Reduces the PT on Beam Therapeutics (BEAM), Keeps a Buy Rating
Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the Best Small-Cap Growth Stocks to Buy Right Now.
11 Best Small-Cap Growth Stocks to Buy Right Now
On August 14, Jonathan Krinsky of BTIG joined CNBC for an interview to discuss the sustainability of the recent small-cap rally.
12 Oversold NASDAQ Stocks to Buy Now
On July 14, Max Kettner, chief multi-asset strategist at HSBC, appeared on CNBC to talk about the global markets amid trade tensions.
H.C. Wainwright Reiterates a Buy Rating on Beam Therapeutics (BEAM) With an $80 PT
Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On July 1, H.C.
Hedge Fund Resource Center Billionaire Hedge Funds
